Under construction – not a live service
Sign in
Taking peopleNo phase

Clinical Trial to Compare Two Surgical Approaches to the Cochlea

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Radboud University Medical Center
Trial code
NCT06453343
Record updated
25 February 2025
Original description
This is a prospective multicenter multinational randomized control trial. The duration of the study for the individual patient will be approximately 1 year (pre-operative assessments, 1 week, 3 months and 12 months follow-up assessments). Participants will be randomized to one of two surgical approaches: eRW or CO, with a 1:1 allocation in a parallel design.Read full original descriptionShow less

Multicenter Randomized Controlled Trial Comparing Surgical Approaches to the Cochlea for the Slim Modiolar Electrode: Assessing Intracochlear Trauma Using Intraoperative Electrocochleography Measurements and Preservation of Residual Hearing

This is a prospective multicenter multinational randomized control trial. The duration of the study for the individual patient will be approximately 1 year (pre-operative assessments, 1 week, 3 months and 12 months follow-up assessments). Participants will be randomized to one of two surgical approaches: eRW or CO, with a 1:1 allocation in a parallel design.

Inclusion: Individuals aged 18 years and older who have clinically established post-linguistic sensorineural hearing loss; CI candidate based on local or national reimbursement criteria; Cochlear implantation with a CI632; Preoperative 500 Hz pure-tone air conduction threshold <80 dB hearing level (HL) in the ear to be implanted; Willing and able to provide written informed consent.

Exclusion: Previous or existing CI recipient; Active middle ear infection; Ossification or other anatomical abnormalities of the cochlea or its windows possibly affecting normal electrode array insertion; Abnormal cochlear nerve anatomy on preoperative CT or MRI; Subjects who are unable to undergo CT or MRI; Deafness due to acoustic nerve or central auditory pathway lesions; Diagnosis of auditory neuropathy; Additional handicaps that would prevent participation in study evaluations; Unrealistic expectations from the participant regarding the possible benefits, risks, and limitations inherent to the CI procedure and the investigation; Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.

ClinicalTrials.gov NCT06453343